Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
PainFever
Interventions
DRUG

Intravenous ibuprofen

400 mg or 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes

Trial Locations (13)

10032

Columbia, New York

19096

Lankenau, Wynnewood

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27599

The University of North Carolina Hospitals, Chapel Hill

27710

Duke University Medical Center, Durham

30303

Grady, Atlanta

33136

University of Miami - Miller School of Medicine, Miami

43210

The Ohio State University Medical Center, Columbus

44111

Fairview, Cleveland

92103

UCSD, San Diego

06810

Danbury, Danbury

02215

Beth Israel Deaconnes MC, Boston

27401-1020

The Moses H. Cone Memorial Hospital, Greensboro

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY

NCT01334944 - Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Biotech Hunter | Biotech Hunter